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Various cellular and molecular events underlie the elevation and fusion of the developing palate that occurs during embryonic development.
This includes convergent extension, where the medial edge epithelium is intercalated into the midline epithelial seam. We examined the expression
patterns of Wnt11 and Fgfr1b – which are believed to be key factors in convergent extension – in mouse palate development. Wnt-11
overexpression and beads soaked in SU5402 (an Fgfr1 inhibitor) were employed in in vitro organ cultures. The results suggested that interactions
between Wnt11 and Fgfr1b are important in modulating cellular events such as cell proliferation for growth and apoptosis for fusion. Moreover,
the Wnt11 siRNA results showed that Wnt11-induced apoptosis was necessary for palatal fusion. In summary, Fgfr1b induces cell proliferation in
the developing palate mesenchyme so that the palate grows and contacts each palatal shelf, with negative feedback of Fgfs triggered by excessive
cell proliferation then inhibiting the expression of Fgfr1b and activating the expression of Wnt11 to fuse each palate by activating apoptosis.
© 2007 Elsevier Inc. All rights reserved.Keywords: Wnt11; Fgfr1b; Palatogenesis; Palatal growth; Palatal fusion; Cell proliferation; Apoptosis; z-VAD-fmk; Wnt11 siRNAIntroduction
Various cellular and molecular mechanisms underlie the
elevation and fusion of the palate shelves that are integral to
normal mammalian palatogenesis (Taniguchi et al., 1995; Gritli-
Linde, 2007; Lee et al., 2007). Two palatal shelves grow from
the internal surfaces of the maxillary primordia once the
development of the secondary palate is initiated, and at
embryonic day 13.5 (E13.5) in mouse they appear vertically
on each side of the tongue, elevating to a horizontal position
above the tongue at E14.0 (Ferguson, 1987). From E14.0 to
E14.5 the palatal shelves make contact and start the fusion
necessary for correct morphogenesis (Johnston and Bronsky,
1995), and by E14.5 they are fused with one another from the
middle region to the anterior and posterior regions to transform
the medial edge epithelium (MEE) into the midline epithelial⁎ Corresponding author. Fax: +82 2 312 8012.
E-mail address: hsjung@yuhs.ac (H.-S. Jung).
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doi:10.1016/j.ydbio.2007.11.033seam (MES) (Martýnez-Alvarez et al., 2000; Chou et al., 2004).
Then, at E15.5, the MES is completely removed from the fused
palate. The fate of the MEE, which is known to form the MES
upon palatal shelf fusion, is still debated. Previous studies have
revealed that the cleft secondary palate originates from a failure
of signaling molecules and their receptors to control prolifera-
tion and fusion (Thyagarajan et al., 2003; Yu et al., 2005; Chai
and Maxson, 2006). Several mutation studies have revealed that
a cleft palate results from intrinsic disruptions to the cellular and
molecular events controlling palatal shelf growth, elevation, or
fusion (Gritli-Linde, 2007). Fgf10−/− mice show cleft palate
because of abnormal fusion between the palatal shelves and the
tongue or mandible (Alappat et al., 2005). Moreover, several
defects in craniofacial development, including cleft palate, have
been observed in skeletal preparations of Wnt1 and Fgfr1
mutant newborns (Trokovic et al., 2003).
The sequence of morphological changes in palatogenesis can
be considered similar to processes in other types of organogen-
esis, such as body axis formation, which is also called con-
vergent extension (Tudela et al., 2002). Convergent extension is
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one axis and lengthens in the perpendicular axis and is critical
to the formation of the vertebrate body axis (Keller et al.,
1985; Wallingford et al., 2002). Signaling molecules such as
Wnt11 and Fgfr1 are closely associated with convergent
extension movement during other types of organogenesis,
including mouse kidney development (Majumdar et al., 2003;
Chi et al., 2004).
The Wnt gene family encodes a conserved class of secreted
signaling molecules and is considered to be one of the major
gene families essential for correct embryonic pattern and
organogenesis (Wodarz and Nusse, 1998; Maye et al., 2004;
Yue et al., 2006). Wnt11 promotes the calcium pathway (Du et
al., 1995; He et al., 1997; Maye et al., 2004; Nelson and Nusse,
2004) that is involved in cell adhesion (Torres et al., 1996) and
inhibition of the canonical Wnt signaling pathway (Ishitani et
al., 2003; Widelitz, 2005). Wnt11 is also essential for the
canonical Wnt pathway activity in dorsal axis formation (Tao et
al., 2005). However, the expression pattern and function of
Wnt11 in palatogenesis have not been elucidated.
In this study, we focused on the interaction with the Wnt
pathway since FGF/Wnt cross-talk is emerging as an important
nexus in the regulation of various biological processes. Wnt
signaling is reported to be closely linked to Fgf signaling in
the development of other organs, such as controlling the
elongation of digits and tip formation (Sanz-Ezquerro and
Tickle, 2003). Therefore, it is certain that Fgf expression is
closely related to Wnt signaling during tip formation, which
represents genetic evidence of a molecular link between the
Wnt and Fgf signaling pathways in the patterning of the
nascent mesoderm. Moreover, members of the Fgf family
regulate Snail, which is the key modulator of cell survival
during palate development (Rice et al., 2004) and a regulator
of epithelial–mesenchymal transformation (EMT) during
gastrulation (Carver et al., 2001).
To investigate the molecular interactions betweenWnt11 and
Fgfr1b, we employed an overexpression method as a gain of
function and treatment with pharmacological inhibitors as a loss
of function with an in vitro palate culture system. Moreover, we
treated Wnt11 small interfering RNA (siRNA) during in vitro
palate culture to confirm the functional significance ofWnt11 in
regulating palatal fusion. This study revealed the precise
functions of cellular modulations controlled by the expression
of specific genes, with the findings elucidating the unique
genetic encoding underlying palatal development.
Materials and methods
All experiments complied with the guidelines of the Intramural Animal Use
and Care Committee, College of Dentistry, Yonsei University.
Animals
Adult ICR mice were housed in a temperature-controlled room (22 °C)
under artificial illumination (lights on from 05:00 to 17:00 h) and at 55% relative
humidity with access to food and water ad libitum. The embryos were obtained
from time-mated pregnant mice. E0 was designated as the day on which the
presence of a vaginal plug was confirmed. Embryos at developmental stage
E13.5–E15.5 were investigated.In vitro organ culture
The palatal shelves were isolated from E13.5 mouse maxillae and cultured in
medium without fetal bovine serum at 37 °C and 5% CO2 for 48 h using a slight
modification of the culture method reported by Trowell (Taya et al., 1999). The
culture medium (DMEM/F12, Gibco) was supplemented with 20 μg/ml ascorbic
acid (Sigma) and 1% penicillin/streptomycin and was renewed every 24 h.
Tissues were then fixed and processed for in situ hybridizations, TUNEL assay,
and immunohistochemistry. At least 10 specimens were examined in each
experiment.
Whole-mount in situ hybridization
Specimens were fixed overnight in 4% paraformaldehyde in phosphate-
buffered saline (PBS). For in situ hybridization the specimens were treated with
20 μg/ml proteinase K for 3 min at room temperature (Kim et al., 2005).
Antisense RNA probes were labeled with digoxigenin (Roche). After in situ
hybridization, the specimens were cryosectioned at a thickness of 25 μm. At
least five specimens were examined in each stage.
Expression constructs
pEGFP-N1 (Clontech) was used for tagging Wnt11 protein with EGFP.
Plasmid DNA was purified using a plasmid purification kit (Qiagen) and
dissolved in TE [10 mM Tris–HCl (pH 8.0) and 0.25 mM EDTA].
Electroporation of organ cultures
The Wnt-11 expression construct (1 μg/μl) in PBS was injected into both
palatal epithelium and mesenchyme using a microcapillary needle, and 20-ms
current pulses were applied using an electroporator. Before the injection, fast
green (diluted 1:10,000; Sigma) was added to the DNA solution for visualization
within the tissue. At least 10 specimens were examined in each experiment.
Bead implantation
AG-1X2 (Bio-Rad Laboratories) formate-derived beads were incubated in
10mMSU5402 (Calbiochem) for 1 h at room temperature. Beadswere implanted
on the palatal shelf at E13.5. After 48 h of culture in vitro, the palate was used for
whole-mount in situ hybridization, TUNEL assay, and immunohistochemistry.
At least 10 specimens were examined in each experiment.
Immunohistochemistry and TUNEL assay
The specimens were embedded in OCT compound using conventional
methods. Sections (7 μm thick) of the specimens were incubated at 4 °C
overnight with the primary mouse monoclonal antibody against proliferating
cell nuclear antigen (PCNA, NeoMarkers). After washing with PBS, the
specimens were allowed to react with biotinylated goat antimouse immunoglo-
bulins and streptavidin peroxidase at room temperature for two consecutive 10-
minute incubations. Finally, the specimens were visualized using a 3,3′-
diaminobenzidine (DAB) reagent kit (Zymed). ATUNEL assay was performed
using an in situ cell apoptosis detection kit (Trevigen) following the
manufacturer's instructions. The 7-μm-thick sections were treated with
proteinase K [in 10 mM Tris–HCl (pH 8.0)] at a concentration of 20 μg/ml
for 15–20 min at room temperature. The samples were then incubated with the
labeling reaction mixture at 37 °C for 1 h and streptavidin–HRP solution for
10 min at room temperature. DAB was used as a substrate solution to detect the
sites of in situ apoptosis under a light microscope. At least 10 specimens were
examined in each experiment.
In vitro organ culture with the apoptosis inhibitor z-VAD-fmk
In the experimental treatments, media were supplemented with 25 μM,
50 μM, or 100 μM z-VAD-fmk (FK-009 z-VAD (OMe)-CH2F O-methylated,
Enzyme Systems Products) in DMSO (Sigma, USA) for 2 days. At least 10
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group were observed in each experiment.
Small interfering RNA treatment
A 500 nM siRNA solution was prepared as follows. A siRNA stock
(50 μM) was diluted with DMEM/F12 medium containing transfection
reagent (siPORT™NeoFX™, Ambion) and then incubated for 10 min at room
temperature. Scrambled control siRNA (Silencer® Negative-Control siRNA,
Ambion) and Wnt11 siRNA (Silencer® Predesigned siRNA; siRNA ID
65306, Ambion) were applied at a final concentration of 500 nM (Shiomi et
al., 2006; Nakajima et al., 2007). siRNA solutions (2 ml) were applied to each
culture plate containing five sets of paired palatal shelves. The palatal fusion
process was confirmed by characterizing the MES region after culturing for
72 h from E13.5.
Real-time quantitative PCR
Total RNA was isolated from the cultured palate using the RNeasy® Mini
Kit (Qiagen). For cDNA synthesis, reverse transcription was performed using
M-MuLV reverse transcriptase (New England BioLabs). Real-time quantitative
PCR (RT-qPCR) was performed using Thermal Cycler Dice™ Real Time
System (TP800, Takara) with SYBR Premix EX Taq™ (Takara). The
amplification program consisted of 45 cycles of denaturation at 95 °C for 5 s,
annealing at 55 °C for 20 s, and extension at 72 °C for 20 s. The results of RT-
qPCR for each sample were normalized β-actin. The data were analyzed with
the Thermal Cycler Dice™ Real Time System analysis software (Takara). The
results were expressed as normalized ratios. The primer sequences of the genes
are as follows: β-actin, 5′-ATTGCCGACAGGATGCAGA-3′ (forward) and 5′-
GAGTACTTGCGCTCAGGAGGA-3′ (reverse); Wnt11 (designed by Takara
Bio), 5′-GGATCCCAAGCCAATAAACTGATG-3′ (forward) and 5′-
TTGAGGTCAGCAGCCACGTC-3′ (reverse); and Fgfr1b, 5′-GGGAATTAA-
TAGCTCGGATGA-3′ (forward) and 5′-ACGCAGACTGGTTAGCTTCA-3′
(reverse). Data were expressed as mean±SD. The mean expression levels were
compared between the experimental and control groups using ANOVA (SPSS
10.0), with a probability value of Pb0.05 (Tukey's HSD test) being considered
statistically significant.Results
Expression patterns of Wnt11 and Fgfr1b in the developing
mouse palate
Wnt11 expression was examined by in situ hybridization at
E13.5, E13.75, E14.0, and E14.5 (Figs. 1A–H). Each specimen
was frontally sectioned at the level of the black dotted lines in
the figure (Figs. 1A–P). At E13.5, Wnt11 was not expressed in
the anterior to posterior regions of the secondary palate (Fig. 1A)
or in either the epithelium or mesenchyme of the palatal shelf
(Fig. 1E). However, at E13.75 the palatal shelves were elevated
above the tongue but were still not in contact with each other,
and Wnt11 was strongly expressed in the MEE region of the
palatal shelves (Fig. 1B) and on the nasal to oral sides of the
palatal shelf epithelium (Fig. 1F). At E14.0, the middle parts of
the palatal shelves began to make contact with each other.Wnt11
was expressed in the epithelium of the MEE region of both the
contacted and noncontacted parts of the palatal shelves (Fig.
1C), and the expression was strong in the MES and on the nasal
and oral sides of the fusion region in the palatal epithelium (Fig.
1G). At E14.5, Wnt11 expression was observed along the entire
fusion line (Fig. 1D) and was strong on the oral and nasal sides
of the palatal epithelium (Fig. 1H) but weak in the MES region.At E13.5, Fgfr1b was expressed from the anterior to middle
regions of the mouse secondary palate (Fig. 1I). Frontal sections
showed that Fgfr1b was expressed in the palatal mesenchyme
of the MEE region (Fig. 1M). The expression pattern of Fgfr1b
did not change after elevation and fusion (Figs. 1J–L). At
E13.75, Fgfr1b was expressed from the anterior to middle
regions of the palatal shelves (Fig. 1J) and in the palatal
mesenchyme, similar to E13.5 (Fig. 1N). At E14.0, Fgfr1b was
expressed from the anterior to middle regions of the secondary
palate (Fig. 1K). Interestingly, Fgfr1b was not expressed at all
in the region of palatal contact of both the epithelium and
mesenchyme (Fig. 1O). At E14.5, Fgfr1b was expressed
throughout the anterior and posterior regions of the secondary
palate (Fig. 1L). Frontal sections revealed strong Fgfr1b
expression in the mesenchymal region (Fig. 1P).
Alteration of gene expression patterns after applying
SU5402-soaked beads and Wnt11 overexpression
In order to compare the molecular regulation betweenWnt11
and Fgfr1b, Wnt-11 was artificially overexpressed in the
developing secondary palate, and beads soaked with the Fgfr1
inhibitor SU5402 were implanted in in vitro organ cultures at
E13.5 for 48 h (Figs. 2A–D). In culture, the two palatal shelves
grew toward each other to fill the initial gap of 0.04 mm to
establish palatal contact. In this stage, the MEE region also grew
and migrated with the palatal shelves. This made it difficult to
inject the expression construct ofWnt-11 and to implant SU5402
beads exactly at the MEE position.Wnt11was expressed only in
the palatal epithelium, in the MEE and MES regions. Therefore,
we attempted to induce Wnt-11 overexpression only in the
palatal epithelium, avoiding the mesenchyme. However, it was
technically impossible to microinject the Wnt-11 construct only
in the epithelium, and hence the construct was injected into both
the palatal epithelium and mesenchyme.
Wnt-11 was overexpressed, as shown within the red dotted
circle in Fig. 2A. Wnt-11 was successfully transfected, as
judged by GFP expression (Fig. 2A′). Moreover, RT-qPCR was
performed to confirm whether the Wnt-11 was successfully
transfected (Fig. 2E). The level of Wnt11 differed significantly
between the Wnt-11 overexpressed and control groups. Relative
to the control on the right side (Fig. 2A), Wnt-11 overexpression
led to the inhibition of Fgfr1b expression at the anterior to
middle regions after 48 h. The expression of Fgfr1b was weaker
on the Wnt-11 overexpressed side than on the control side (Fig.
2C). Moreover, the expression of Wnt11 was upregulated at
48 h after implanting SU5402-soaked beads (Fig. 2B), and
SU5402 strongly induced Wnt11 expression on the oral side of
the palatal epithelium and weakly in the underlying mesench-
yme (Fig. 2D). These results indicate thatWnt11 is related to the
Fgfr1 pathway.
Alterations to cellular events after treatment with
SU5402-soaked beads and Wnt11 overexpression
Cell death was examined in control andWnt-11 overexpressed
specimens (Fig. 3A). Significantly, many apoptotic cells were
Fig. 1. (A–P) Wnt11 and Fgfr1b expressions are detected by whole-mount in situ hybridization and sectioning. Only frontal sections are shown. (A, E) At E13.5,
Wnt11 is expressed weakly in the posterior region but not in the middle region of the palatal shelf. (B, F) At E13.75, Wnt11 is expressed along the MEE region,
with strong expression in the palatal epithelium. (C) At E14.0, Wnt11 is expressed in the MEE region and contact area between the palatal shelves. (G) Wnt11 is
strongly expressed in both the MEE (arrows) and MES. (D) At E14.5,Wnt11 expression is restricted along the fusion line of the palate. (H) Wnt11 is expressed in the
palatal epithelium on both the oral and nasal sides of the palate. (I, J) Fgfr1b is expressed in the anterior to middle regions at E13.5 and E13.75. (M, N) Fgfr1b is
expressed in the palatal mesenchyme. (K) After the initiation of palatal contact at E14.0, Fgfr1b is expressed in the anterior to middle regions of the palate. (O) There is
no Fgfr1b expression in the region of palatal contact in either the epithelium or mesenchyme. (L) At 14.5, Fgfr1b is expressed from the anterior to posterior regions of
the palate. (P) Fgfr1b expression is strong in the middle region of the palatal mesenchyme. ant, anterior; black dotted line, section plane; post, posterior; ps, palatal
shelf; scale bars: A–D, I–L, 500 μm; E–H, M–P, 200 μm.
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Wnt-11 overexpressed domain compared to the control domain
(Fig. 3A). In addition, TUNEL-positive cells were observed in
the epithelium of the midline region, indicating fusion of the two
developing palates. On the Wnt-11 overexpressed side, strong
positive reactions for cell death were identified in the epithelium
and underlying mesenchyme (Fig. 3C), while few TUNEL-
positive cells were observed on the control side (Fig. 3D). The
vector control showed that TUNEL-positive cells were not
altered at E13.5 (data not shown). On the other hand, the number
of PCNA-positive cells differed between the experimental and
control sides after 48 h (Fig. 3G). The number of PCNA-positive
was clearly lower in the Wnt-11 overexpressed region than in the
control (Figs. 3I and J). To determine whether Fgf signaling is
involved in the maintenance and/or induction of cell death and in
proliferation in secondary palate development, beads soaked in
SU5402 (10 mM) were implanted on one side of the palatal shelf
and cultured for 48 h (DMSO as the control), and TUNEL and
PCNA were applied to the developing palate (Figs. 3B and H).
SU5402 altered the number of apoptotic cells (Fig. 3B). AfterSU5402 beads implantation at E13.5, the number of TUNEL-
positive cells was clearly higher than in the control after 48 h
(Figs. 3E and F). SU5402 also altered cell proliferation (Fig.
3H). The number of proliferating cells was lower around
SU5402-soaked beads than in the control during palate
development (Figs. 3K and L). The numbers of TUNEL- and
PCNA-positive cells were not altered in the control after
implanting DMSO-soaked beads (data not shown).
Inhibition of apoptosis by z-VAD-fmk treatment disrupted
palate fusion
In order to investigate the effect of z-VAD-fmk treatment as
an inhibitor of apoptosis, developing palates were cultured in
media containing 25 μM, 50 μM, or 100 μM z-VAD-fmk for
48 h. H–E staining of serial frontal sections revealed differences
between the DMSO controls and z-VAD-fmk-treated specimens
(Figs. 4A–C). In the controls, developing pairs of palates were
completely fused after 48 h (n=9/10) (Fig. 4A). The fate of the
MES in the experimental group clearly differed with the dose,
Fig. 2. (A, C) Overexpressed Wnt-11 alters Fgfr1b expression pattern. Electroporation is applied between the anterior and middle regions of the palate (red dotted
circle). All specimens are electroporated at E13.5 and then incubated for 48 h. Wnt-11 is successfully transfected, as indicated by the GFP expression (A′). After Wnt-
11 overexpression, Fgfr1b expression is downregulated in these regions (arrows). (B, D) SU5402-soaked beads (10 mM, asterisk) are implanted into the palate at
E13.5 and the specimens are then incubated for 48 h. Expression ofWnt11 is upregulated strongly in the epithelium and weakly in the mesenchyme by the implantation
of SU5402-soaked beads (arrowheads). (E) Expression levels of Wnt11 are examined by RT-qPCR in the palate at E13.5 after 48 h of culturing. Wnt11 expression
levels increase dramatically after Wnt-11 overexpression relative to control groups. *Pb0.05 as determined by ANOVA; asterisk, bead; red dotted circle, DNA
injection region; white dotted line, boundary of the cultured palate; scale bars: A, B, 500 μm; C, D, 100 μm.
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palatal fusion (n=11/14), with some MES cells remaining
(arrowheads in Fig. 4B), while MES cells still remained
(arrowheads in Fig. 4C) with z-VAD-fmk at a high concentra-
tion (50 μM) (n=12/14) (Fig. 4C), with similar results for
100 μM z-VAD-fmk (n=11/11) (data not shown).
The number of TUNEL-positive cells was counted in a
100 μm2 region of both control and z-VAD-fmk-treated
specimens. The number of apoptotic cells was significantly
lower after z-VAD-fmk treatment than in the DMSO control
(Figs. 4D–F, and data not shown), with the difference
increasing with the concentration of z-VAD-fmk. There were
8.7 TUNEL-positive cells/100 μm2 in the palate of DMSO
control specimens (Fig. 4D, and data not shown), but 4.6 cells/
100 μm2 after treatment with 25 μM z-VAD-fmk. However,
palatal shelves were fused with the MES particles (arrowheads
in Fig. 4B) only on the oral and nasal sides (Figs. 4B and E, and
data not shown). Moreover, there were only 2 cells/100 μm2 in
specimens treated with 50 μM or 100 μM z-VAD-fmk (Fig. 4F,
and data not shown).
Wnt11 knockdown using siRNA
To determine the function ofWnt11 during palatogenesis, we
performed a gene knockdown investigation usingWnt11 siRNA
(siRNA ID 65306, Ambion). Wnt11 siRNA was applied at
500 nM to palatal shelves at E13.5, which were then cultured for
72 h. After in vitro culture, we performed H–E staining to
identify alterations to the pattern of palatogenesis (Figs. 5A–C).
There were no morphological differences between the control
siRNA treatment group and the control group (n=13/15) (Figs.
5A and B), with the MES completely disappearing and the
palatal shelves fusing. However, there were morphological
differences between the Wnt11 siRNA treatment group and thecontrol siRNA treatment group (Figs. 5B and C). After
treatment with 500 nM Wnt11 siRNA, the MES was still
detected in the midline of the palate (n=15/15) (arrowheads in
Fig. 5C). In order to understand the precise relationship between
Wnt11 and apoptosis, we performed TUNEL staining after
treatment with Wnt11 siRNA (Figs. 5D–F). In control and
control siRNA, apoptotic bodies decreased with the disappear-
ance of the MES (Figs. 5D and E). As expected, Wnt11
knockdown by siRNA inhibited apoptosis in the remaining
MES (Fig. 5F). RT-qPCR was used to examine the effectiveness
of the siRNA system. Significant differences were found after
Wnt11 siRNA treatment. The level of Wnt11 was lower in the
500 nM Wnt11 siRNA treatment group than in the control and
control siRNA treatment groups (n=24) (Fig. 5G). In order to
confirm the relationship between Wnt11 and Fgfr1b in
palatogenesis, we used RT-qPCR to evaluate the expression
level of Fgfr1b after Wnt11 siRNA treatment. The expression
level of Fgfr1b was dramatically higher in the Wnt11 siRNA
treatment group than in the control and control siRNA treatment
groups (n=15) (Fig. 5H).
Discussion
Expression patterns of Wnt11 and Fgfr1b in the developing
secondary palate
Convergent extension has been examined during palatogen-
esis when MEE cells intercalate to the MES during palatal
fusion (Tudela et al., 2002). Convergent extension as regulated
by Wnt11 is also critical to the formation of the vertebrate body
axis (Jopling and den Hertog, 2005). The relationships between
convergent extension and the Wnt11 and Fgfr1 genes in
gastrulation cell movements have been reported (Chung et al.,
2005; Jopling and den Hertog, 2005). In addition, Wnt11 and
Fig. 3. (A, G) TUNEL and PCNA assay on frontal sections after overexpression studies in cultured palates (at E13.5+48 h). (A, C, D) The number of TUNEL-positive
cells increased markedly after Wnt-11 overexpression. (A) TUNEL-positive cells are detected in the epithelium of the fusion region (arrowheads). (C) Overexpressed
Wnt-11 induces apoptosis in the epithelium and in the mesenchyme beneath the epithelium (arrowheads), but not on the control side. (D) A few apoptotic cells are
detected on the control side. (G, I, J) Overexpressed Wnt-11 alters the cell proliferation rate in the cultured palate relative to the control side. (I, J) There are fewer
PCNA-positive cells on the Wnt-11 overexpressed side than on the control side. (B, H) Cell death and proliferation are examined after implanting SU5402-soaked
beads (10 mM) for 48 h. (B) SU5402 alters the cell death rate during palate development. (E) Apoptotic cells are induced near the SU5402 beads (green dotted circle).
(F) A few TUNEL-positive cells are evident on the control side. (H) Implanting SU5402-soaked beads altered the number of PCNA-positive cells. (K, L) SU5402-
soaked beads decreased the number of PCNA-positive cells relative to the control side. Blue dotted line, border of epithelium and mesenchyme; e, epithelium; green
dotted circle, bead; scale bars: A, B, G, H, 200 μm; C–F, I–L, 20 μm.
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the branching morphogenesis in the kidney of the mouse
(Majumdar et al., 2003; Chi et al., 2004; Tao et al., 2005). In the
present study, we hypothesized that Wnt11 and Fgfr1b were
involved in palatogenesis, whose cellular mechanisms are
similar to convergent extension. While Wnt11 and Fgfr1b play
important roles in convergent extension (Trokovic et al., 2003),
the precise molecular interactions between Wnt11 and Fgfr1b
underlying palatogenesis have not been elucidated. In order to
understand the function of Wnt11 and Fgfr1b, we examined
gene expression patterns between E13.5 and E14.5 using in situ
hybridization since these developmental stages are critical to
palate formation. Prior to fusion, the expression patterns of
Wnt11 in the margin of the palatal shelf epithelium suggested
that Wnt11 is involved in the fusion of the palatal shelves. In
contrast, Fgfr1b was expressed in the developing palatalmesenchyme from the anterior to posterior regions. Particularly
at E14.0, when palatal contact is initiated, Fgfr1b was not
expressed in either the palatal epithelium or mesenchyme along
the palatal margin (Fig. 1). These temporal expression patterns
of Wnt11 and Fgfr1b during palate development suggest that
they play important roles through interactions or cascade
pathways.
Wnt11 and Fgfr1b modulate the cellular events during
palatogenesis
To clarify the molecular interactions between Wnt11 and
Fgfr1b during palatogenesis, Wnt-11 overexpression – repre-
senting an enhancement of the function of Wnt11 – was
examined using an electroporation method. The results clearly
showed that the expression of Fgfr1b was downregulated in the
Fig. 4. (A–F) H–E and TUNEL staining are examined after applying 25 μM or 50 μM z-VAD-fmk. (A) After 48 h in culture, the two palatal shelves are completely
fused in the DMSO control group. (B) After treatment with 25 μM z-VAD-fmk, the two palatal shelves are fused with the MES particle (arrowheads) only on the oral
and nasal sides. (C) Palatal shelves are not fused with the MES in specimens treated with 50 μM z-VAD-fmk (arrowheads). (D–F) The number of TUNEL-positive
cells is significantly lower in z-VAD-fmk-treated specimens than in the control group cultured with DMSO. (D) More apoptotic cells are detected in DMSO controls
than in z-VAD-fmk treatment. (E) The number of apoptotic cells is reduced after treatment with 25 μM z-VAD-fmk relative to the control group. (F) Few apoptotic
bodies are detected in the palate in specimens treated with 50 μM z-VAD-fmk. Purple dotted line, remaining MES; ps, palatal shelf; scale bars: A–F, 100 μm.
Fig. 5. (A–F) H–E and TUNEL staining are examined after 500 nM siRNA treatment. (A, B) The palatal shelves are completely fused in the control and control siRNA
treatment groups. (C) However, the MES remained (arrowheads) and the palatal shelves are not fused in the group treated with 500 nMWnt11 siRNA. (D–F) TUNEL
staining revealed no significant positive reaction of apoptosis in the MES region both in the control and siRNA treatment groups. (D and E) Apoptotic bodies are
reduced with the disappearance of the MES. (F) There is no positive TUNEL staining in the remaining MES region. (G)Wnt11 expression level is detected in cultured
palate (at E13.5+72 h). The level of Wnt11 expression is significantly lower after treatment with 500 nM Wnt11 siRNA than in the control and control siRNA
treatment groups. (H) Expression levels of Fgfr1b are examined in the cultured palate (at E13.5+72 h). Fgfr1b expression levels are dramatically increased after
Wnt11 siRNA treatment relative to the control and control siRNA treatment groups. *Pb0.05 as determined by ANOVA; arrowheads, remainingMES; scale bars: A–F,
100 μm.
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348 J.-M. Lee et al. / Developmental Biology 314 (2008) 341–350developing palate (Fig. 2). Moreover, knockdown using Wnt11
siRNA induced the intensity of Fgfr1b (Fig. 6H), which
suggests that a specific pathway of Wnt11 regulates Fgfr1b
during palatogenesis. Wnt11 expression was upregulated by the
implantation of SU5402-soaked beads, concomitant with the
loss of function of Fgfr1 (Fig. 2). Thus, mesenchymal
expression of Fgfr1b would negatively regulate the epithelial
expression of Wnt11. These altered expression patterns of
Wnt11 and Fgfr1b suggest that Fgfr1b and Wnt11 negatively
regulate each other during palatogenesis.
Based on the specific expression patterns of Wnt11 in the
MEE and MES during palatogenesis, we hypothesized that
Wnt11 is involved in palatal fusion, which is induced by
apoptosis. Recent studies have shown that apoptosis plays
important roles in palatal fusion (Vaziri Sani et al., 2005) and
that members of the Wnt family regulate cell death both
positively and negatively (Lobov et al., 2005). In order to
understand the function of Wnt11, electroporation was
performed for overexpression of Wnt-11 away from the MEE.
Naturally, Wnt11 was expressed in the MEE and MES regions
of the epithelium (Fig. 1). Apoptotic cells were also detected in
the MES where Wnt11 expressed region (Fig. 3). We therefore
attempted to avoid overlap between normal Wnt11 expressions
and overexpressed Wnt-11, injecting the Wnt-11 expression
construct away from the MEE. TUNEL staining after Wnt-11
overexpression revealed that Wnt11 modulates cell death in
palatogenesis. Inhibition of Fgfr1 by SU5402 altered cell
proliferation and apoptosis in the developing palate, suggesting
that the Fgfs influence the cellular events including cell
proliferation and apoptosis in palate development either directly
or indirectly. These results are consistent with previous studies
that have provided evidence of molecular interactions between
Fgf and Fgfrs in palatogenesis (Garcia-Maya et al., 2006; Ziv et
al., 2006).
These results suggest that cell proliferation – which is
reported to be closely related to the elevation of the developing
palate – would be regulated in part by Fgfr1b, whereas Wnt11
potentially regulates palatal fusion by mediating cell death.
Furthermore, the relationship between Fgfr1b and Wnt11 isFig. 6. The molecular interactions between Wnt11 and Fgfr1b modulate various
development. Black blunt arrow, previous finding; blue arrow, positive modulation;required for correct processes of palatal development, such as
proliferation and fusion induced by apoptosis.
Apoptosis for palatal fusion is modulated by molecular
interactions between Wnt11 and Fgfr1b
Vaziri Sani et al. (2005) reported that the fate of the MES
during palatal development is still controversial. Previous
studies showed that apoptosis eliminates some MEE cells,
which results in the correct migration and differentiation during
palatal fusion (Mori et al., 1994; Taniguchi et al., 1995; Cuervo
and Covarrubias, 2004). However, Takahara et al. (2004) used a
palate organ culture with apoptosis inhibitors to demonstrate
that cell death is not required for mammalian palatogenesis.
Moreover, there is ultrastructural and molecular evidence of
EMT in the disappearing MES cells (Martýnez-Alvarez et al.,
2000), although more recent in vivo genetic fate-mapping
results showed that the occurrence of EMT is mutually
contradictory during palatal fusion (Vaziri Sani et al., 2005;
Jin and Ding, 2006).
Based on our in vitro Wnt-11 overexpression results, we
suggest thatWnt11 induces apoptosis in the palatal epithelium and
mesenchyme through inhibition ofFgfr1b, which plays important
roles in cell proliferation. However, Wnt-11 overexpression was
not sufficient to elucidate function of apoptosis in palatal fusion.
We examined the precise role of apoptosis in palatal fusion by
treating sampleswith the pancaspase inhibitor z-VAD-fmk, which
blocked the apoptosis induced by p21 (Wood and Newcomb,
1999) (Fig. 4). The H–E staining results suggest that treatment
with z-VAD-fmk at a concentration greater than 50 μM disrupted
palate fusion by decreasing the number of apoptotic cells.
Based on previous studies (Shiomi et al., 2006; Nakajima et
al., 2007), siRNA treatment was used in the present study to
examine the functional significance of Wnt11 in regulating
palatal fusion (Fig. 5). Majumdar et al. (2003) reported that
Wnt11 mutant mice showed various problems, such as a smaller
kidney and ureteric and kidney branching defects. However,
cleft palate has not been reported in Wnt11 transgenic mice. In
the present study, we treated with Wnt11 siRNA at E13.5 forcellular events including cell proliferation and apoptosis to ensure correct
e, epithelium; m, mesenchyme; red blunt arrow, negative modulation.
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examination of gene regulation in a time- and tissue-specific
manner. Our use of this in vitro culture system with Wnt11
siRNA confirmed that Wnt11 was closely related to palatal
fusion. As we hypothesized, knockdown of Wnt11 resulted in
the failure of palatal fusion, which also occurred after treatment
with z-VAD-fmk. After in vitro culture at E13.5 for 72 h, palatal
shelves were completely fused with elimination of the MES via
apoptosis (Figs. 3A, 5D and E). However, after Wnt11 siRNA
treatment, apoptotic cells were not detected even when the MES
did not disappear (Fig. 5F). These results suggest thatWnt11 is a
key factor for palatal fusion through the induction of apoptosis.
Molecular interactions govern cellular modulations in
palatogenesis
Our results appear to demonstrate that cellular modulations
controlled by molecular interactions between Wnt11 and
Fgfr1b are important to the correct development of the palate
in three critical phases during palatogenesis. In the first (growth)
phase between E13.5 and E14.0, Fgfr1b induce cell prolifera-
tion and inhibitWnt11 expression (Fig. 6A). Inhibitory feedback
loops downstream of FGF signaling factors regulate signal
propagation via a MAP kinase cascade downstream of FGF
receptor activation (Eblaghie et al., 2003). In the second
(contact) phase at E14.0, negative feedback of Fgf-induced cell
proliferation would gradually inhibit Fgfr1 expression over
time (Garcia-Maya et al., 2006), which might in turn cause the
gradual expression ofWnt11, inducing apoptosis in the adjacent
epithelium (Fig. 6B). In the third (fusion) phase at E14.5,
Wnt11-induced apoptosis in the epithelium (MES) would be
eliminated over time, resulting in Fgfr1b being gradually
expressed for growth of the fused palate (Fig. 6C). The results
of z-VAD-fmk treatment revealed that Wnt11-mediated apop-
tosis is closely related to palate fusion in this third phase.
Interactions between Wnt11 and Fgfr1b could represent a
pivotal cellular-control mechanism for achieving the precise
morphogenesis of the secondary palate. The model is steady
with the data at hand, but given the rapid advancing of the field,
no doubt the model will need some dynamic remodeling over
time as additional pathways and molecular cross-talk emerge.
An understanding of the unique developmental processes
underlying palatogenesis will help to elucidate the fundamental
molecular mechanisms underlying cleft palate. We propose that
Wnt/Fgfr cross-talk plays an important, cell-autonomous role in
regulating the fate of MEE cells during palatogenesis in both
mice and humans. Future studies should examine the factors
that play fundamental roles in mediating palate development
using experimental model system, such as microarray, to
understand the precise molecular mechanisms underlying
palatal development.
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